Valuation: OneSource Specialty Pharma Limited

Market Cap 192B 2B 1.76B 1.63B 1.5B 2.83B 2.89B 19.4B 7.61B 94.19B 7.53B 7.36B 325B P/E 2026
-229x
P/E 2027 * 46.3x
Enterprise Value 203B 2.12B 1.86B 1.72B 1.58B 2.99B 3.05B 20.5B 8.04B 99.5B 7.95B 7.78B 344B EV / Sales 2026
12.7x
EV / Sales 2027 * 9x
Free-Float
61.96%
Yield 2026 *
-
Yield 2027 * -
1 day+2.83%
1 week+0.24%
Current month+1.53%
1 month+3.75%
3 months+16.27%
6 months-3.74%
Current year-7.60%
1 week 1,506.1
Extreme 1506.1
1,720
1 month 1,506.1
Extreme 1506.1
1,740
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
2,088
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2024
Director of Finance/CFO - 04/07/2024
Compliance Officer - 14/03/2023
Director TitleAgeSince
Director/Board Member 65 07/04/2021
Director/Board Member 54 01/03/2024
Director/Board Member 66 27/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
+2.83%+0.24%-15.48% - 1.96B
+0.44%+1.41%+4.25%+10.81% 50.73B
-1.57%-3.18%+379.41%+593.37% 39.73B
-0.14%+0.77%+29.61%-5.50% 34.69B
+1.76%-1.78%+20.55%+53.38% 33.21B
-0.06%-4.63%+2.94%+31.65% 26.76B
-1.93%-1.01% - - 16.8B
-1.49%-6.18%+65.50%+120.53% 15.37B
+0.78%+1.16%+15.53%+17.32% 13.78B
-0.97%-2.83%+11.09%-33.29% 12.85B
Average -0.06%-1.13%+57.04%+98.53% 24.59B
Weighted average by Cap. -0.21%-0.40%+80.37%+124.23%

Financials

2026 2027 *
Net sales 13.41B 140M 123M 114M 105M 198M 202M 1.36B 532M 6.59B 526M 515M 22.75B 22.3B 233M 204M 189M 174M 329M 336M 2.26B 885M 10.95B 875M 856M 37.83B
Net income -1.19B -12.44M -10.91M -10.1M -9.3M -17.58M -17.92M -120M -47.23M -585M -46.7M -45.68M -2.02B 4.13B 43.19M 37.88M 35.08M 32.28M 61.06M 62.24M 418M 164M 2.03B 162M 159M 7.01B
Net Debt 10.81B 113M 99.03M 91.72M 84.4M 160M 163M 1.09B 429M 5.31B 424M 415M 18.33B 8.86B 92.53M 81.16M 75.17M 69.16M 131M 133M 896M 351M 4.35B 347M 340M 15.02B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,412
Date Price Change Volume
13/07/26 1,673.00 +2.83% 713,625
10/07/26 ₹1,626.90 +0.07% 960,506
09/07/26 ₹1,625.70 +0.85% 238,106
08/07/26 ₹1,612.00 -0.91% 399,660
07/07/26 ₹1,626.80 -2.18% 869,705
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,673.00INR
Average target price
2,036.75INR
Spread / Average Target
+21.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock